Voya Investment Management LLC lessened its holdings in Cabot Corporation (NYSE:CBT – Free Report) by 61.9% during the third quarter, HoldingsChannel.com reports. The fund owned 9,786 shares of the specialty chemicals company’s stock after selling 15,932 shares during the quarter. Voya Investment Management LLC’s holdings in Cabot were worth $744,000 at the end of the most recent quarter.
Other hedge funds and other institutional investors have also made changes to their positions in the company. Elevation Point Wealth Partners LLC acquired a new stake in Cabot in the 2nd quarter valued at $28,000. Parkside Financial Bank & Trust lifted its position in Cabot by 95.5% during the 2nd quarter. Parkside Financial Bank & Trust now owns 387 shares of the specialty chemicals company’s stock worth $29,000 after acquiring an additional 189 shares in the last quarter. Geneos Wealth Management Inc. grew its position in Cabot by 409.0% in the first quarter. Geneos Wealth Management Inc. now owns 453 shares of the specialty chemicals company’s stock valued at $38,000 after acquiring an additional 364 shares in the last quarter. UMB Bank n.a. raised its stake in shares of Cabot by 52.4% during the second quarter. UMB Bank n.a. now owns 730 shares of the specialty chemicals company’s stock valued at $55,000 after purchasing an additional 251 shares during the period. Finally, EverSource Wealth Advisors LLC grew its holdings in Cabot by 344.3% during the 2nd quarter. EverSource Wealth Advisors LLC now owns 813 shares of the specialty chemicals company’s stock valued at $61,000 after purchasing an additional 630 shares in the last quarter. Institutional investors and hedge funds own 93.18% of the company’s stock.
Wall Street Analyst Weigh In
CBT has been the subject of a number of analyst reports. UBS Group decreased their price objective on shares of Cabot from $82.00 to $65.00 and set a “neutral” rating for the company in a research report on Wednesday, November 5th. Weiss Ratings reissued a “hold (c-)” rating on shares of Cabot in a report on Monday. Zacks Research lowered Cabot from a “hold” rating to a “strong sell” rating in a research report on Friday, November 7th. Mizuho raised their price target on shares of Cabot from $72.00 to $80.00 and gave the stock an “outperform” rating in a research report on Thursday, December 18th. Finally, JPMorgan Chase & Co. dropped their target price on shares of Cabot from $75.00 to $54.00 and set an “underweight” rating for the company in a research report on Friday, November 28th. One equities research analyst has rated the stock with a Buy rating, two have assigned a Hold rating and two have given a Sell rating to the stock. According to MarketBeat, the stock currently has an average rating of “Reduce” and an average price target of $66.33.
Cabot Trading Down 0.2%
Shares of NYSE CBT opened at $66.31 on Thursday. Cabot Corporation has a 12-month low of $58.33 and a 12-month high of $92.89. The company has a market cap of $3.51 billion, a price-to-earnings ratio of 11.03, a price-to-earnings-growth ratio of 3.48 and a beta of 0.90. The company has a current ratio of 1.61, a quick ratio of 1.08 and a debt-to-equity ratio of 0.50. The stock’s 50 day simple moving average is $64.89 and its 200 day simple moving average is $72.47.
Cabot (NYSE:CBT – Get Free Report) last issued its quarterly earnings data on Monday, November 3rd. The specialty chemicals company reported $1.70 EPS for the quarter, missing analysts’ consensus estimates of $1.72 by ($0.02). The company had revenue of $899.00 million for the quarter, compared to the consensus estimate of $967.02 million. Cabot had a return on equity of 24.55% and a net margin of 8.91%.Cabot’s quarterly revenue was down 10.2% compared to the same quarter last year. During the same quarter in the previous year, the company earned $1.80 earnings per share. Cabot has set its FY 2026 guidance at 6.000-7.00 EPS. Equities research analysts expect that Cabot Corporation will post 7.57 EPS for the current year.
Cabot Announces Dividend
The company also recently disclosed a quarterly dividend, which was paid on Friday, December 12th. Investors of record on Friday, November 28th were given a $0.45 dividend. The ex-dividend date was Friday, November 28th. This represents a $1.80 annualized dividend and a yield of 2.7%. Cabot’s dividend payout ratio (DPR) is currently 29.95%.
About Cabot
Cabot Corporation is a global specialty chemicals and performance materials company headquartered in Boston, Massachusetts. Founded in 1882 by Godfrey Lowell Cabot, the company has grown into a diversified manufacturer with operations across North America, Europe, Asia and Latin America. Cabot serves a wide range of end markets, including automotive, industrial, energy, and consumer products, supplying essential ingredients that enhance performance, durability and functionality.
The company operates two primary segments: Reinforcement Materials and Performance Materials.
Featured Articles
- Five stocks we like better than Cabot
- The Best $1 You’ll Spend This Holiday Season
- Holiday surprise: $1 gets you everything
- America’s “most deplorable” Christmas sale
- Do not delete, read immediately
- Market Panic: Trump Just Dropped a Bomb on Your Stocks
Want to see what other hedge funds are holding CBT? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Cabot Corporation (NYSE:CBT – Free Report).
Receive News & Ratings for Cabot Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cabot and related companies with MarketBeat.com's FREE daily email newsletter.
